Provexis plc (AIM: PXS)
London
· Delayed Price · Currency is GBP · Price in GBX
0.459
-0.064 (-12.28%)
Nov 21, 2024, 9:52 AM GMT+1
Provexis Company Description
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide.
The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats.
It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company’s website and distributors.
Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Provexis plc
Country | United Kingdom |
Founded | 1999 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2 |
CEO | Ian Ford |
Contact Details
Address: 2 Blagrave Street Reading, RG1 1AZ United Kingdom | |
Phone | 44 7490 391888 |
Website | provexis.com |
Stock Details
Ticker Symbol | PXS |
Exchange | London Stock Exchange AIM |
Fiscal Year | April - March |
Reporting Currency | GBP |
ISIN Number | GB00B0923P27 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Ian Ford | Chief Executive Officer |
Ian Ford | Chief Financial Officer |